Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1985 | |
| Sales | 140,361 |
| Cost of Goods | 95,100 |
| Gross Profit | 45,261 |
| Operating Expenses | 26,197 |
| Operating Income | 19,164 |
| Other Income | 1,450 |
| Pre-tax Income | 20,614 |
| Income Tax | 8,254 |
| Net Income Continuous | 11,858 |
| Net Income | $11,858 |
| EPS Basic Total Ops | 0.05 |
| EPS Basic Continuous Ops | 0.05 |
| EBITDA(a) | $19,164 |